» Articles » PMID: 21813201

Long-term Prognosis of Patients with Lung Cancer Detected on Low-dose Chest Computed Tomography Screening

Overview
Journal Lung Cancer
Specialty Oncology
Date 2011 Aug 5
PMID 21813201
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The effectiveness of lung cancer screening using low-dose chest computed tomography (CT) remains elusive. The present study examined the prognosis of patients with lung cancer detected on CT screening in Japanese men and women. Subjects were 210 patients with primary lung cancer identified on CT screening at two medical facilities in Hitachi, Japan, where a total of 61,914 CT screenings were performed among 25,385 screenees between 1998 and 2006. Prognostic status of these patients was sought by examining medical records at local hospitals, supplemented by vital status information from local government. The 5-year survival rate was estimated according to the characteristics of patients and lung nodule. A total of 203 (97%) patients underwent surgery. During a 5.7-year mean follow-up period, 19 patients died from lung cancer and 6 died from other causes. The estimated 5-year survival rate for all patients and for those on stage IA was 90% and 97%, respectively. Besides cancer stage, smoking and nodule appearance were independent predictors of a poor survival; multivariable-adjusted hazard ratio (95% confidence interval) was 4.7 (1.3, 16.5) for current and past smokers versus nonsmokers and 4.6 (1.6, 13.9) for solid nodule versus others. Even patients with solid shadow had a 5-year survival of 82% if the lesion was 20mm or less in size. Results suggest that lung cancers detected on CT screening are mostly curative. The impact of CT screening on mortality at community level needs to be clarified by monitoring lung cancer deaths.

Citing Articles

Gender Disparities and Lung Cancer Screening Outcomes Among Individuals Who Have Never Smoked.

Kim Y, Joo D, Kim S, Park Y, Jang S, Lee J JAMA Netw Open. 2025; 8(1):e2454057.

PMID: 39813033 PMC: 11736501. DOI: 10.1001/jamanetworkopen.2024.54057.


Race, age at diagnosis and histological characteristics of lung cancer in never-smokers (LCINS) and ever-smokers in low-dose computed tomography (LDCT) screening: a systematic review and meta-analysis.

Triphuridet N, Nagasaka M, Shum E, Ou S Transl Lung Cancer Res. 2024; 13(5):1047-1060.

PMID: 38854936 PMC: 11157373. DOI: 10.21037/tlcr-23-816.


Prediction of the stage shift growth of early-stage lung adenocarcinomas by volume-doubling time.

Tang E, Wu Y, Chen C, Wu F Quant Imaging Med Surg. 2024; 14(6):3983-3996.

PMID: 38846271 PMC: 11151246. DOI: 10.21037/qims-23-1759.


Managing Persistent Subsolid Nodules in Lung Cancer: Education, Decision Making, and Impact of Interval Growth Patterns.

Liu Y, Liang C, Wu Y, Chen C, Tang E, Wu F Diagnostics (Basel). 2023; 13(16).

PMID: 37627933 PMC: 10453827. DOI: 10.3390/diagnostics13162674.


Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity.

Qu R, Tu D, Cai Y, Ping W, Fu X Front Oncol. 2022; 12:979522.

PMID: 36185186 PMC: 9515497. DOI: 10.3389/fonc.2022.979522.